Effects Of ARRY-797, A P38 Map Kinase Inhibitor, In Animal Models Of Pulmonary Inflammation Via Oral, Intratracheal Or Aerosol Delivery

MLA

Albion D. Wright, et al. “Effects Of ARRY-797, A P38 Map Kinase Inhibitor, In Animal Models Of Pulmonary Inflammation Via Oral, Intratracheal Or Aerosol Delivery.” B35. MUCOSAL IMMUNOLOGY AND INFLAMMATION, May 2011. EBSCOhost, https://doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2831.

APA

Albion D. Wright, Mark C. Munson, Thomas Pope, Stefan Gross, Pheneger Jed, Robert D. Groneberg, Laurence E. Burgess, Patrice Lee, & Corey Custer. (2011). Effects Of ARRY-797, A P38 Map Kinase Inhibitor, In Animal Models Of Pulmonary Inflammation Via Oral, Intratracheal Or Aerosol Delivery. B35. MUCOSAL IMMUNOLOGY AND INFLAMMATION. https://doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2831

Chicago

Albion D. Wright, Mark C. Munson, Thomas Pope, Stefan Gross, Pheneger Jed, Robert D. Groneberg, Laurence E. Burgess, Patrice Lee, and Corey Custer. 2011. “Effects Of ARRY-797, A P38 Map Kinase Inhibitor, In Animal Models Of Pulmonary Inflammation Via Oral, Intratracheal Or Aerosol Delivery.” B35. MUCOSAL IMMUNOLOGY AND INFLAMMATION, May. doi:10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2831.